Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Treasury Shares: 2009-2025

Historic Treasury Shares for Cumberland Pharmaceuticals (CPIX) over the last 15 years, with Sep 2025 value amounting to $58,947.

  • Cumberland Pharmaceuticals' Treasury Shares fell 78.57% to $58,947 in Q3 2025 from the same period last year, while for Sep 2025 it was $58,947, marking a year-over-year decrease of 78.57%. This contributed to the annual value of $339,200 for FY2024, which is 15.65% down from last year.
  • As of Q3 2025, Cumberland Pharmaceuticals' Treasury Shares stood at $58,947, which was up 3,174.83% from $1,800 recorded in Q2 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Treasury Shares peaked at $568,181 during Q4 2021, and registered a low of $1,800 during Q2 2025.
  • Its 3-year average for Treasury Shares is $165,636, with a median of $99,057 in 2023.
  • Its Treasury Shares has fluctuated over the past 5 years, first spiked by 89.86% in 2022, then slumped by 97.66% in 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Treasury Shares (Quarterly) stood at $568,181 in 2021, then plummeted by 30.35% to $395,751 in 2022, then climbed by 1.62% to $402,143 in 2023, then dropped by 15.65% to $339,200 in 2024, then slumped by 78.57% to $58,947 in 2025.
  • Its Treasury Shares was $58,947 in Q3 2025, compared to $1,800 in Q2 2025 and $53,837 in Q1 2025.